Exhibit 10.3   



EMPLOYMENT AGREEMENT 




        This
Agreement, between Bradley Pharmaceuticals, Inc., a Delaware corporation with principal
executive offices located at 383 Route 46 West, Fairfield, New Jersey 07004 (the “Company”),
and Bradley Glassman (“Employee”), is made and entered into as of this 6th day
of December, 2005 (the “Effective Date”). 




R E C I T A L S  




        WHEREAS,
the Company believes that Employee has been an integral part of the Company’s
management team and is and will continue to be integral to the continued implementation
of the Company’s business plan and execution of its growth strategy; and 




        WHEREAS,
as a result of Employee’s extensive knowledge and acumen regarding the business,
affairs and operations of the Company, the Company desires assurance of the continued
association and services of Employee in order to benefit from Employee’s experience,
skills, abilities, background and knowledge, and the Company is willing to engage Employee’s
services on the terms and conditions set forth in this Agreement; and 




        WHEREAS,
Employee desires to continue to render services to the Company and to remain in the
employ of the Company, and is willing to accept continued employment from the Company on
the terms and conditions set forth in this Agreement; and 




        WHEREAS,
the Company and Employee wish to enter into a written Employment Agreement to supersede
all other written and oral understandings and agreements regarding Employee’s
employment with the Company. 




        NOW,
THEREFORE, based on the foregoing recitals and in consideration of the commitments set
forth below, Employee and the Company agree as follows: 



        1.
Position, Duties, Responsibilities  



	  	        1.1.
Position. Employee is hereby employed by the Company as the Company’s
Senior Vice President, Sales and Marketing effective at the Effective Date, reporting
directly to the Company’s Chief Executive Officer. Employee shall accept such duties
and responsibilities as may be delegated, from time to time, by the Chief Executive
Officer, including serving as an officer and/ or director of the Company’s
subsidiaries or affiliates; provided that such duties and responsibilities are consistent
with the duties and responsibilities customarily assigned to an officer of similar title
of a company similar to the Company. Employee shall devote his full energies, interest,
abilities and business time to the proper, efficient, diligent and faithful performance
of these duties.  







	  	        1.2.
Other Activities. Without the prior written consent of the Company’s
Board of Directors, Employee shall not during the Term (as hereinafter defined) of this
Agreement engage or participate, directly or indirectly, as an employee, director,
consultant, investor or otherwise, in any business, trade or occupation, or company,
other than as an investor in a  








 
	 	
1	 
















company whose securities are quoted
or traded on a nationally recognized exchange, provided Employee holds not more than five
per cent (5%) in aggregate of any class of shares, debentures or other securities or not
more than five per cent (5%) of the economic value of the company. Nothing herein shall
require Employee to dispose of any securities currently held. Employee may serve in any
capacity with any civic, educational or charitable organization, or any governmental
entity or trade association, without seeking or obtaining the Company’s approval,
provided such activities and services do not materially interfere or conflict with the
performance of his duties under this Agreement. Nothing herein shall limit any applicable
restrictions under the Company’s Corporate Governance Guidelines or other codes of
conduct from time to time in effect. 



	  	        1.3.
Proprietary Information. Employee recognizes that his employment with the
Company will involve contact with proprietary and other information of substantial value
to the Company which is not generally known in the trade or available in the public
domain and which gives the Company an advantage over its competitors who do not know or
use such proprietary or other information (collectively, “the Company Confidential
Information”). As a condition to the employment by the Company of Employee
hereunder, Employee agrees to sign and return a copy of the Company’s
Confidentiality Agreement attached hereto as Exhibit A. In addition, to the extent
any of the Company Confidential Information or inventions, innovations, improvements,
processes or other proprietary information is created, authored or conceived by Employee
(whether alone or with others) during the course of his employment with the Company
(collectively, “Works”), (a) Employee will promptly disclose full details of
all such Works to the Company, (b) Employee shall cause all such Works to vest solely
legally and beneficially in the Company immediately without any payment to Employee, (c)
Employee hereby assigns to the Company all of Employee’s right, title and interest
in the Works, (d) Employee hereby irrevocably authorizes the Company to be his
attorney-in-fact, and to make use of his name and to sign and execute, any documents and/
or perform any act on his behalf, for the purpose of giving the Company full benefit of
this Section 1.3 and, where permissible, to obtain patent or other protection in respect
of any of the Works in the name of the Company or the Company’s nominee and (e)
Employee, both during his employment under this Agreement and thereafter, at the request
and expense of the Company, will promptly do all things and execute all documents
reasonably necessary to obtain and/ or maintain patent or other protection in respect of
any Works in any part of the world and to vest such rights in and to any Works in the
name of the Company or the Company’s nominee.  







	  	        1.4.
Covenant Not to Compete. Employee agrees that for a period of twelve (12) months
immediately following the Term of this Agreement, Employee shall not directly or
indirectly for his own benefit or the benefit of others: 







	 	                           (a)  	  	render
services as an employee, officer,                                     agent, broker,
consultant, partner or                                     independent contractor for, or
be an owner                                     or stockholder of, a competing
organization                                     in connection with competing products,
                                    including but not limited to organizations
                                    engaged in the provision of dermatology,
                                    podiatry and gastroenterology pharmaceutical
                                    products; provided, however, that Employee
                                    may own five percent (5%) or less of the
                                    equity securities of any publicly-traded
                                    company; 








 
	 	
2	 















	 	                           (b)  	  	hire
or seek to persuade any employee of the                                     Company to
discontinue employment or to                                     become employed in a
competing organization                                     or seek to persuade any
independent                                     contractor or supplier to discontinue or
                                    limit its relationship with the Company; and 






	 	                           (c)  	  	solicit,
direct, take away or attempt to                                     take away any
business or customers of the                                     Company that existed or
did business with                                     the Company at the time of
termination of                                     Employee’s employment hereunder
or                                     within six (6) months prior thereto; 






provided, however, that such
restrictions shall not apply if Employee’s employment hereunder is terminated
without Cause (as defined below) or Employee terminates his employment hereunder for Good
Reason (as defined below), regardless of whether a Change of Control (as defined below)
has occurred. 





	  	        Employee
acknowledges that there are no additional compensation payments due him for the
non-competition restrictions set forth in this Section 1.4. 







        2.
Compensation of Employee  



	  	        2.1.
Salary. In consideration of the services to be rendered by Employee under the terms of
this Agreement, the Company shall pay Employee an annual salary of $260,000, subject to
standard deductions and withholdings, payable in regular periodic payments in accordance
with the Company’s policies. The Board of Directors and Compensation Committee of
the Company will review Employee’s salary not less frequently than annually (with
the first review to occur in April 2006) and, in its discretion, may increase, but not
decrease, Employee’s annual salary hereunder. 







	  	        2.2.
Stock Options. Subject to approval by the Board of Directors and Compensation Committee
of the Company, Employee shall be entitled to receive, from time to time during the Term,
such options to purchase shares of the Company’s common stock and other similar
securities of the Company on such terms and conditions as the Board of Directors and
Compensation Committee of the Company may establish. 







	  	        2.3.
Benefits and Perquisites. Employee shall be eligible to participate in all of the Company’s
bonus, health, welfare, savings and other benefit and fringe benefit plans, including,
without limitation, the Company’s EVA Bonus Plan, 401(k) Savings Plan, health,
dental and eye insurance plans, life insurance plans and long-term disability plans, in
which senior executives of the Company are generally entitled to participate, subject, at
all times, to the terms and conditions of such plans. In addition, Employee shall receive
such other perquisites and benefits, including a leased automobile, gasoline credit card
and paid vacation days, as the Company generally makes available to its senior executives. 







	  	        2.4.
Expense Reimbursement. The Company shall promptly reimburse Employee for all reasonable
and necessary business and entertainment expenses incurred by Employee in connection with
his performance of his duties hereunder in accordance with the Company’s usual
reimbursement policies and procedures in effect from time to time. In addition, 









 
	 	
3	 
















the Company will pay all reasonable
out-of-pocket attorneys’ fees incurred by Employee in connection with the
negotiation of this Agreement and any matters arising out of or relating to any dispute
hereunder that Employee has brought in good faith, subject to any limitations imposed
under Section 409A of the Internal Revenue Code of 1986, as amended, and any guidance
issued thereunder (“Section 409A of the Code”). 



        3.
Term  



	  	        Employee’s
employment under this Agreement shall commence as of the Effective Date and shall
continue until the third anniversary thereof (the “Expiration Date”), unless
sooner terminated by the Company or Employee in accordance with this Agreement (the “Term”);
provided, however, that this Agreement shall renew automatically for an additional term
of one (1) year on the Expiration Date and each anniversary of the Expiration Date unless
the Company or Employee gives written notice to the other to the contrary at least 90
days prior thereto. References herein to “Term” shall include any automatic
extensions pursuant to the preceding sentence. 









        4.
Termination of Employment  



	  	        4.1.
Termination by the Company for Cause. The Company may terminate Employee’s
employment hereunder for “Cause” (as defined below), provided that the Company
has complied with the provisions of this Section 4.1. For purposes of this Agreement,
“Cause” shall mean any of the following: 







	 	                           (a)  	  	Employee’s
conviction for any felony; 








	 	                           (b)  	  	Employee’s
deliberate and continual                                     refusal to perform
satisfactorily employment                                     duties reasonably requested
by the Company                                     as provided herein after thirty (30)
                                    days’ written notice by certified mail
                                    of such failure, specifying that the failure
                                    constitutes Cause and the particulars of the
                                    failure (other than as a result of vacation,
                                    sickness, illness or injury); 








	 	                           (c)  	  	Employee’s
commission of fraud or                                     embezzlement determined in
accordance with                                     the Company’s normal, internal
                                    investigative procedures consistently
                                    applied in comparable situations; 








	 	                           (d)  	  	Employee’s
gross misconduct or gross                                     negligence having a
substantial adverse                                     effect on the Company’s
business; or 








	 	                           (e)  	  	Employee’s
material breach of this                                     Agreement. 








	  	        The
Company shall  provide  Employee  notice of such  termination  in accordance  with
Section 13 hereof. 









 
	 	
4	 

















	  	        Employee
shall be considered to have been terminated for “Cause” if the Company in good
faith determines Employee engaged in an act constituting “Cause,” regardless of
whether Employee voluntarily terminates his employment or is terminated involuntarily. 









	  	        If
the Company terminates Employee’s employment for Cause, Employee shall be entitled
to a lump sum cash payment, payable within ten (10) business days after the date of
termination of Employee’s employment for Cause, equal to the sum of (i) any accrued
but unpaid salary as of the date of such termination, (ii) any accrued but unpaid annual
cash bonus payable under the Company’s EVA Bonus Program for any annual period ended
prior to the date of such termination, and (iii) all expenses incurred for which
documentation has been or will be provided in accordance with the Company’s policies
but not yet reimbursed. In the event of the termination of Employee’s employment for
Cause, Employee’s stock options and any other equity awards based on the Company’s
securities, such as restricted stock, restricted stock units, stock appreciation rights,
performance units, etc. shall, to the extent then vested and exercisable, remain vested
and exercisable in accordance with their terms, and any such unvested awards shall be
immediately forfeited and/or cancelled. 









	  	        4.2.
Termination by the Company Without Cause. The Company may terminate Employee’s
employment without Cause, which termination shall be effective upon Employee’s
receipt of written notice of the same in accordance with this Agreement. Upon any
termination of Employee’s employment by the Company without Cause pursuant to this
Section 4.2, Employee shall be entitled to: 







	 	                           (a)  	  	a
lump sum cash payment, payable within ten                                     (10)
business days after the date of                                     termination of
Employee’s employment                                     equal to the sum of: (i)
any accrued but                                     unpaid salary as of the date of such
                                    termination; (ii) any accrued but unpaid
                                    annual cash bonus payable under the
                                    Company’s EVA Bonus Program for any
                                    annual period ended prior to the date of
                                    such termination; and (iii) all expenses
                                    incurred for which documentation has been or
                                    will be provided in accordance with the
                                    Company’s policies but not yet
                                    reimbursed; 








	 	                           (b)  	  	a
lump sum cash payment, payable within ten                                     (10)
business days of the date that is six                                     (6) months
following the date of termination                                     (or, if Employee is
not considered a                                     “key employee” within the
meaning                                     of Section 409A of the Code at the time of
                                    termination, the date Employee’s
                                    employment terminates), equal to the amount
                                    payable under the Company’s EVA Bonus
                                    Program for the annual period in which such
                                    termination occurs, as if the
                                    Employee’s employment had not been
                                    terminated, prorated through the date of
                                    such termination; 








	 	                           (c)  	  	continuation
of all perquisites and other                                     Company-related benefits
to which Employee                                     was entitled as of the date of his
                                    termination, including, but not limited to,
                                    those set forth in Section 2.3 above,
                                    through the end of the second calendar year
                                    following the year in which Employee’s
                                    employment terminates, if and to the extent
                                    the  









 
	 	
5	 

















	  	
provision
of such perquisites or                                     benefits complies with Section
409A of the                                     Code; 








	 	                           (d)  	  	immediate
vesting of all of Employee’s                                     stock options,
warrants and any other equity                                     awards based on Employer’s
securities,                                     such as restricted stock, restricted
stock                                     units, stock appreciation rights,
                                    performance units, etc., all of which shall
                                    remain exercisable in accordance with the
                                    original terms on the date of grant, or, if
                                    later, the maximum date stock rights may be
                                    extended under Section 409A of the Code; 








	 	                           (e)  	  	continued
participation in, and continuation                                     by the Company of
the payment of the                                     relevant premiums applicable to,
the life                                     insurance and health, welfare and medical
                                    insurance plans described in Section 2.3 or
                                    comparable plans at the Company’s
                                    expense (subject to the terms of the
                                    applicable plans) through the end of the
                                    second calendar year following the year in
                                    which Employee’s employment terminates,
                                    if and to the extent the provision of
                                    continued participation and payments of
                                    premiums complies with Section 409A of the
                                    Code; 








	 	                           (f)  	  	continued
participation, through the end of                                     the second calendar
year following the year                                     in which Employee’s
employment                                     terminates, of Employee and each of his
                                    dependents in all other Company-sponsored
                                    health, welfare and benefit plans or
                                    comparable plans at the Company’s
                                    expense (subject to the terms of the
                                    applicable plans) at the benefit levels in
                                    effect from time to time and with COBRA
                                    benefits commencing thereafter, if and to
                                    the extent the provision of continued
                                    benefits and benefit levels complies with
                                    Section 409A of the Code and any other
                                    applicable laws and regulations. 








	  	        In
addition to the foregoing payments and continuation of benefits, the Company shall pay
Employee a lump sum cash payment, payable within ten (10) business days of the date that
is six (6) months following the date of termination of Employee’s employment (or, if
Employee is not considered a “key employee” within the meaning of Section 409A
of the Code at the time of termination, the date Employee’s employment terminates),
an amount equal to the product of (I) two multiplied by (II) the sum of (1) Employee’s
then current annual salary pursuant to Section 2.1 and (2) the average amount paid to
Employee under the Company’s EVA Bonus Program with respect to the most recent three
calendar years (or such shorter period to coincide with Employee’s years of
employment with the Company prior to the end of the preceding calendar year). 







	  	        Notwithstanding
 anything  in this  Agreement  to the  contrary,  if at the time of  termination,
Employee is a “specified employee” or “key employee” who has
experienced a “separation from service,” each within the meaning of Section
409A of the Code, no payments or benefits pursuant to this Agreement that are considered
“deferred compensation” subject to Section 409A of the Code shall be made prior
to the date that is six (6) months after the date of  








 
	 	
6	 
















“separation from service” (or,
if earlier, Employee’s date of death), except as otherwise provided in the Code,
Section 409A of the Code or any regulations promulgated thereunder. In such event, the
payments subject to the six (6) month delay will be paid in a lump sum on the earliest
permissible payment date. 



	  	        4.3.
Termination by Employee for Good Reason. Employee may terminate his employment hereunder
for “Good Reason.” For purposes of this Agreement, “Good Reason” shall
mean, without Employee’s consent, the occurrence of any of the following
circumstances unless such circumstances are fully corrected prior to the expiration of
the thirty (30) day period following receipt by the Company of Employee’s notice of
the existence of circumstances that provide a basis for Employee to terminate his
employment for Good Reason, describing such circumstances in reasonable detail: 







	 	                           (a)  	  	a
substantial diminution or unreasonable                                     increase in
Employee’s duties,                                     responsibilities or
authority, taken as a                                     whole (except during periods
when Employee                                     is unable to perform all or
substantially                                     all of Employee’s duties or
                                    responsibilities as a result of
                                    Employee’s physical or mental
                                    incapacity); 








	 	                           (b)  	  	a
change in Employee’s principal place                                     of
employment to a location more than 50                                     miles from its
current location; or 








	 	                           (c)  	  	a
material breach of this Agreement by the                                     Company. 








	  	        If
Employee terminates his employment with the Company for Good Reason, subject to the
Company’s right to cure as set forth above, Employee shall be entitled to the same
payments and benefits, at the same times, set forth in Section 4.2 above for a
termination by the Company without Cause. 









	  	        4.4.
Termination by Employee Without Good Reason. Employee shall have the right to terminate
his employment voluntarily hereunder at any time without Good Reason upon 30 days’ written
notice to the Company. Upon any voluntary termination of employment by Employee without
Good Reason pursuant to this Section 4.4, Employee shall be entitled only to such
payments and benefits as those described in Section 4.1 for a termination by the Company
for Cause. 









	  	        4.5
Termination in Connection with a Change in Control. For purposes of this
Agreement, a “Change in Control” shall mean: 









	 	(a)  	  	 The
 acquisition  by an  individual,  entity or group  (within  the  meaning of
                                    Section  13(d)(3)  or  14(d)(2)  of the  Securities
 Exchange  Act of 1934,  as                                     amended  (the  “Exchange
 Act”)) (a “Person”)  of  beneficial  ownership of any
                                    capital  stock  of  the  Company  if,  after  such
 acquisition,   such  Person                                     beneficially  owns
 (within  the  meaning of Rule 13d-3  promulgated  under the
                                    Exchange Act) 50% or more of either (x) the
 then-outstanding  shares of common                                     stock of the
Company (the  “Outstanding  Company  Common Stock”) or (y)  








 
	 	
7	 













	  	
subject
                                    to  Section  4.5(d),   the  combined  voting  power
 of  the   then-outstanding                                     securities  of the
 Company  entitled  to vote  generally  in the  election  of
                                    directors (the “Outstanding  Company Voting
 Securities”);  provided,  however,                                     that for
purposes of this subsection (a), the following  acquisitions shall not
                                    constitute a Change of Control  Event:  (A) any
 acquisition  directly from the                                     Company  (excluding
 an  acquisition  pursuant to the  exercise,  conversion or
                                    exchange of any security  exercisable for,
convertible into or exchangeable for                                     common  stock
 or  voting   securities  of  the  Company,   unless  the  Person
                                    exercising,  converting  or  exchanging  such
 security  acquired such security                                     directly from the
Company or an underwriter  or agent of the Company),  (B) any
                                    acquisition  by any  employee  benefit  plan (or
related  trust)  sponsored  or                                     maintained by the
Company or any corporation  controlled by the Company, or (C)
                                    any  acquisition  by any  corporation  pursuant to a
Business  Combination  (as                                     defined  below) which
 complies with clauses (x) and (y) of  subsection  (c) of
                                    this definition; or 








	 	                           (b)  	  	Subject
to Section  4.5(d),  such time as the Continuing  Directors (as defined
                                    below) do not  constitute  a majority of the Board of
Directors of the Company,                                     where the term  “Continuing
 Director”  means at any date a member of the Board
                                    (x) who was a member of the Board on the date  hereof
or (y) who was  nominated                                     or elected  subsequent to
such date by at least a majority of the directors who
                                    were  Continuing  Directors at the time of such
nomination or election or whose                                     election  to the
Board was  recommended  or  endorsed by at least a majority of
                                    the directors who were  Continuing  Directors at the
time of such nomination or                                     election;  provided,
however, that there shall be excluded from this clause (y)
                                    any individual  whose initial  assumption of office
 occurred as a result of an                                     actual or threatened
 election  contest with respect to the election or removal
                                    of  directors  or  other  actual  or  threatened
 solicitation  of  proxies  or                                     consents, by or on
behalf of a person other than the Board; or 






	 	                           (c)  	  	The
consummation of a merger, consolidation,  reorganization,  recapitalization
                                    or share exchange  involving the Company or a sale or
other  disposition of all                                     or substantially  all of
the assets of the Company (a “Business  Combination”),
                                    unless, immediately following such Business
Combination,  each of the following                                     two conditions is
satisfied:  (x) all or  substantially  all of the individuals
                                    and entities who were the beneficial  owners of the
Outstanding  Company Common                                     Stock and  Outstanding
 Company  Voting  Securities  immediately  prior to such
                                    Business  Combination  beneficially own, directly or
indirectly,  more than 50%                                     of the  then-outstanding
 shares of common stock and the combined  voting power
                                    of the  then-outstanding  securities entitled to vote
generally in the election                                     of directors,
 respectively,  of the resulting or acquiring  








 
	 	
8	 









	  	
corporation
in such                                     Business  Combination (which shall include,
 without limitation,  a corporation                                     which as a result
of such transaction owns the Company or substantially  all of
                                    the  Company’s  assets  either  directly or
through  one or more  subsidiaries)                                     (such  resulting
 or  acquiring  corporation  is  referred  to  herein  as  the
                                    “Acquiring  Corporation”)  in
 substantially  the  same  proportions  as  their
                                    ownership  of the  Outstanding  Company  Common Stock
and  Outstanding  Company                                     Voting   Securities,
  respectively,   immediately   prior  to  such   Business
                                    Combination  and (y) no Person  (excluding  the
 Acquiring  Corporation  or any                                     employee  benefit
 plan (or  related  trust)  maintained  or  sponsored  by the
                                    Company  or by  the  Acquiring  Corporation)
 beneficially  owns,  directly  or                                     indirectly,  50%
or more of the then-outstanding  shares of common stock of the
                                    Acquiring Corporation,  or of the combined voting
power of the then-outstanding                                     securities of such
 corporation  entitled to vote  generally in the election of
                                    directors  (except  to the  extent  that such
 ownership  existed  prior to the                                     Business
Combination). 






	 	                           (d)  	  	During
the period in which Daniel Glassman                                     and his
affiliates own or control a majority                                     of the Company’s
Class B Common Stock                                     entitled to elect the majority
of the                                     Company’s Board of Directors, a
                                    “Change of Control” shall not be
                                    deemed to have occurred if Mr. Glassman and
                                    his affiliates caused, either by their
                                    action or inaction, the circumstances
                                    contemplated in either Sections 4.5(a)(y) or
                                    4.5(b) to occur. 








	  	        If
a Change in Control occurs during the Term, and if, during the Term and within twelve
months after the date on which the Change in Control occurs, Employee’s employment
is terminated by the Company without Cause or by Employee for any reason, then Employee
will be entitled to the payments and benefits, at the same times, described in Section
4.2 for a termination by the Company without Cause. Additionally, immediately prior to a
Change of Control, all outstanding options to purchase the Company’s securities
shall become fully vested. 









	  	        In
addition, to the extent that any payment or distribution of any type to or for Employee
by the Company (which for purposes of this Section 4.5 includes any parent, subsidiary or
affiliate of the Company), whether paid or payable or distributed or distributable
pursuant to the terms of this Agreement or otherwise (including, without limitation, any
accelerated vesting of stock options or other equity awards based on the Company’s
securities granted pursuant to this Agreement or otherwise) (collectively, the “Total
Payments”) is or will be subject to the excise tax (“Excise Tax”) imposed
under Section 4999 of the Code (or any successor to such Section), the Company shall pay
to Employee, prior to the time any Excise Tax is payable with respect to any of such
Total Payments (through withholding or otherwise), an additional amount (a “Gross-Up
Payment”) that, after the imposition of all income, employment, excise and other
taxes, penalties and interest thereon, is equal to the sum of (i) the Excise Tax on such
Total Payments plus (ii) any penalty and interest assessments associated with such Excise
Tax. The determination of whether any portion of the Total Payments is subject to an
Excise Tax and, if so, the amount and time of any Gross-Up Payment pursuant to this
Section 4.5, shall be made by an independent auditor (the 









 
	 	
9	 

















“Auditor”) jointly
selected by Employee and the Company and paid by the Company. If Employee and the Company
cannot agree on the firm to serve as the Auditor, then they shall each select an
accounting firm and those two firms shall jointly select the accounting firm to serve as
the Auditor. Unless Employee agrees otherwise in writing, the Auditor shall be a
nationally recognized United States public accounting firm that has not during the two
years preceding the date of its selection, acted in any way on behalf of the Company.
Employee and the Company shall cooperate with each other in connection with any
proceeding or claim relating to the existence or amount of any liability for Excise Tax.
All reasonable expenses relating to any such proceeding or claim (including attorneys’ fees
and other expenses incurred by Employee in connection therewith) shall be paid by the
Company promptly upon demand by Employee, and any such payment shall be subject to a
Gross-Up Payment under this Section 4.5 in the event that Employee is subject to Excise
Tax on it. 





	  	        4.6
Death or Disability. In the event of Employee’s death or “Disability” (as
defined below) during the Term, Employee’s employment shall automatically cease and
terminate as of the date of Employee’s death or the effective date of the Company’s
written notice to Employee of its decision to terminate his employment by reason of his
Disability, as the case may be. In the case of termination of Employee’s employment
by reason of his death, Employee’s estate, or in the case of termination of Employee’s
employment by reason of his Disability, Employee shall be entitled to the same payments
and benefits, as applicable, at the same times, as described in Section 4.2 for a
termination of employment by the Company without Cause; provided, however, for purposes
of this Section 4.6, the multiple referred to in the second paragraph of Section 4.2
shall be one (1). Any vested stock options and other equity awards held by Employee at
the time of his termination of employment due to death or Disability shall remain
exercisable in accordance with the original terms on the date of grant through the
maximum date stock rights may be extended under Section 409A of the Code. Notwithstanding
the foregoing or any provision of Section 4.6, the Company’s obligation to pay
Employee the amounts called for in this Section 4.6 following termination of his
employment by reason of his Disability, shall be subject to offset and shall be reduced
by any and all amounts paid to Employee under any disability insurance policy paid or
provided for by the Company. For purposes of this Agreement, “Disability” shall
mean the inability of Employee to perform substantially all of his duties hereunder for
any period of at least 180 consecutive days by reason of any physical or mental
incapacity, provided that for purposes of any payments made to Employee pursuant to this
Section 4.6, “Disability” shall have the meaning set forth in Section 409A of
the Code or, to the extent applicable, any more restrictive definition under the plan or
policy providing for the benefit in question. 









        5.
No Duty to Mitigate  





	  	        Employee
shall have no obligation to seek other employment or to otherwise mitigate the Company’s
obligations to him arising from the termination of his employment, and no amounts paid or
payable to Employee by the Company hereunder shall be subject to offset for any
remuneration to which Employee may become entitled from any other source after his
employment with the Company terminates, whether attributable to subsequent employment,
self-employment or otherwise. 









 
	 	
10	 
















        6.
Termination Obligations  



	  	        Employee
hereby acknowledges and agrees that all books, manuals, records, reports, notes,
software, computer code, contracts, lists, blueprints, and other documents, or materials,
or copies thereof, and equipment (including computers, keys, credit cards, cellular
telephones, etc.) furnished to or prepared by Employee in the course of or incident to
Employee’s employment, belong to the Company and shall be promptly returned to the
Company upon termination of Employee’s employment. 







        7.
Indemnification  





	  	        The
Company shall indemnify Employee and hold him harmless to the fullest extent permitted by
the Company’s charter and by-laws in respect to any and all actions, suits,
proceedings, claims, demands, judgments, losses, damages and reasonable out-of-pockets
costs and expenses (including reasonable out-of-pocket attorney’s fees and expenses)
resulting from Employee’s good faith performance of his duties and obligations with
the Company or as a fiduciary of any benefit plan of the Company. To the extent permitted
by applicable laws, the Company shall, within 30 days of presentation of invoices,
reimburse Employee for all reasonable out-of-pocket legal fees and disbursements
reasonably incurred by Employee in connection with such indemnifiable matter. In
addition, Directors’ and Officers’ insurance coverage for the benefit of
Employee shall cover Employee in respect of acts or omissions committed by Employee in
good faith in the performance of his duties and obligations during his employment
hereunder, whether claims are made during or within the period of six years after the
termination of Employee’s employment hereunder. 









        8.
Entire Agreement  



	  	        The
terms of this Agreement are intended by the parties to be the final and exclusive
expression of their agreement with respect to the subject matter hereof and may not be
contradicted by evidence of any prior or contemporaneous statements or agreements. The
parties further intend that this Agreement shall constitute the complete and exclusive
statement of its terms and that no extrinsic evidence whatsoever may be introduced in any
judicial, administrative, or other legal proceeding involving this Agreement. This
Agreement supersedes any and all prior agreements, written or oral, between Employee and
the Company relating to the subject matter hereof, and all such prior agreements are
hereby terminated and of no further effect. 







        9.
Amendments, Waivers  



	  	        This
Agreement may not be modified, amended, or terminated except by an instrument in writing,
signed by Employee and by a duly authorized representative of the Company other than
Employee. No failure to exercise and no delay in exercising any right, remedy, or power
under this Agreement shall operate as a waiver thereof, nor shall any single or partial
exercise of any right, remedy or power under this Agreement preclude any other or further
exercise thereof, or the exercise of any other right, remedy or power provided herein or
by law or in equity. 








 
	 	
11	 
















        10.
Binding Agreement; Assignment  



	  	        This
Agreement shall inure to the benefit of and shall be binding upon the Company, its
successors and assigns and Employee and his heirs and representatives. Neither party may
assign any of its rights or obligations under this Agreement without the prior written
consent of the other party. 







        11.
Severability; Enforcement  



	  	        If
any provision of this Agreement, or the application thereof to any person, place, or
circumstance, shall be held by a court of competent jurisdiction to be invalid,
unenforceable, or void, the remainder of this Agreement and such provisions as applied to
other persons, places, and circumstances shall remain in full force and effect. Such
court shall have the authority to modify or replace the invalid or unenforceable term or
provision with one which most accurately represents the parties’ intention with
respect to the invalid or unenforceable term or provision. 







        12.
Governing Law and Remedies  



	  	        The
validity, interpretation, enforceability, and performance of this Agreement shall be
governed by and construed in accordance with the laws of the State of New Jersey, without
giving effect to New Jersey’s choice of law rules. Employee hereby irrevocably
submits to the jurisdiction of the federal and state courts within New Jersey for the
determination of all disputes, suits or proceedings arising out of or relating to this
Agreement. 







	  	        Employee
acknowledges that a remedy at law for the breach or threatened breach by Employee of the
provisions of Section 1.3 and 1.4 would be inadequate, and that such a breach would cause
irreparable harm to the Company. Employee therefore agrees that the Company shall be
entitled to injunctive relief in case of any such breach or threatened breach. 







        13.
Notices  



	  	        All
notices or demands of any kind required or permitted to be given by the Company or
Employee to the other under this Agreement shall be given in writing, addressed to the
Company at the address set forth in the Preamble to this Agreement and to Employee at his
address as listed on the Company’s payroll and shall be personally delivered,
telecopied or delivered by hand by a nationally recognized courier service guaranteeing
overnight delivery (in each case receipted for), or mailed by certified mail, return
receipt requested, postage prepaid. Any such written notice shall be deemed received when
personally delivered or three (3) business days after its deposit in the United States
mail as specified above. Either party may change its address for notices by giving notice
to the other party in the manner specified in this Section. 







        14.
Representations and Warranties  



	  	        Each
of Employee and the Company represents and warrants that he/it is not restricted or
prohibited, contractually or otherwise, from entering into and performing his/its terms
and covenants contained herein, and that his/its execution and performance of this
Agreement will not violate or breach any other agreement between Employee and the
Company, as the case may be, and any other person or entity. 









 
	 	
12	 














        15.
Section 409A of the Code  



	  	        Employee
and the Company hereby agree that it is the intention that any payments or benefits
provided under this Agreement comply in all respects with Section 409A of the Code, and
this Agreement shall be interpreted accordingly. Employee and the Company hereby agree
that, upon the Company’s initiative or upon Employee’s reasonable request, the
parties will amend this Agreement in accordance with Section 9 solely to the extent
necessary and appropriate to avoid adverse tax consequences pursuant to Section 409A of
the Code. Notwithstanding anything in this Agreement to the contrary, the Company does
not guarantee the tax treatment of any payments or benefits hereunder, including without
limitation pursuant to the Code, federal, state or local laws. 









        16.
Counterparts  



	  	        This
Agreement may be executed in counterparts, each of which shall be deemed an original and
all of which together shall constitute one and the same instrument. 









 
	 	
13	 













        IN
WITNESS WHEREOF, this Agreement has been executed as of the day and year first above
written. 





	 	                            	  	BRADLEY PHARMACEUTICALS,
INC. 

By: /s/ Daniel Glassman
       Name: Daniel Glassman

       Title:   President and Chief Executive Officer


        EMPLOYEE


       /s/ Bradley Glassman
        Name:  Bradley Glassman







 
	 	
14	 














Exhibit A    



BRADLEY
PHARMACEUTICALS, INC.  



CONFIDENTIALITY
AGREEMENT  



This Agreement is executed by Bradley
Glassman (“Employee”) and made effective as of this 6th day of
December 2005. 



P URPOSE  



Bradley Pharmaceuticals, Inc., a
Delaware corporation with executive offices located at 383 Route 46 West, Fairfield, NJ
07004 (“BDY”), possesses certain information that is considered by it as its
confidential information and trade secrets. Employee is employed as BDY’s Senior Vice
President, Sales and Marketing and, in such capacity, has been privy to, and will continue
to become privy to, confidential information and trade secrets of BDY. Employee hereby
agrees that all such confidential information of BDY shall be maintained by Employee and
protected in accordance with this Agreement. 



T ERMS  



	1.  	  	“Confidential
Information” shall mean all information and           materials relating to BDY,
whether in written, oral, visual, electronic or other           form and which are
designated as confidential or which, under the circumstances           taken as a whole,
reasonably would be understood to be confidential, including,           but not limited
to, the following: (1) discoveries, inventions, unpublished           works, research or
manufacturing methods, formulae and data; (2) the           specifications, composition,
requirements, designs, programming and performance           characteristics for
instruments, software or other products and services; (3)           business, technical
and economic information, product pricing and sales           information, marketing
plans and forecasts, the existence or terms of this           Agreement or agreements
between the parties and other parties, commercialization           and research and
marketing methods or strategies; (4) yet to be filed or pending           patent or
trademark applications; (5) other trade secrets and know-how; and (6)           other
data and materials relating to the subject matter of this Agreement.
          Confidential Information shall also include all notes, reports, analyses,
          forecasts, compilations, studies, interpretations or other documents and
          materials prepared by Employee to the extent the same contain or reflect BDY
          Confidential Information. Information shall not be considered Confidential
          Information to the extent that such information is demonstrated by Employee,
          through clear and convincing written evidence:  






	 	(a)  	  	To
have been in his possession prior to his employment by BDY;  






	 	(b)  	  	To
have been generally and publicly known at the time of disclosure or           thereafter
through no fault of Employee or any other party under any agreement           of
confidentiality to BDY; or  








 
	 	 
	 














	 	(c)  	  	To
have been furnished to Employee by a third party, provided such third party
                    had the legal right to disclose such Confidential Information.  






	  	
Employee
acknowledges and agrees that all Confidential Information is of important commercial and
competitive value to BDY.  






	2.  	  	Employee
shall protect the Confidential Information from unauthorized use,           access,
duplication or further disclosure. In protecting such disclosed           Confidential
Information, Employee shall take, for example, but not by way of           limitation,
the following measures to:  






	 	(a)  	  	Prevent
the access, transfer or disclosure of the Confidential Information by
                    or to any other person or entity other than those employees and
agents of BDY                     who have a “need to know” such Confidential
Information;  






	 	(b)  	  	Other
than in the ordinary course of business, prevent any reproduction of the
                    Confidential Information in any form, tangible, electronic or
otherwise; and  






	 	(c)  	  	Upon
termination of Employee’s employment with BDY, promptly, but in any
                    event within five (5) business days, destroy or return to BDY all
Confidential                     Information and any work product containing, summarizing
or based upon such                     Confidential Information and all copies thereof,
in any form, tangible,                     electronic or otherwise. Employee shall
promptly give BDY written certification                     of his destruction or return
of all Confidential Information as contemplated by                     this paragraph.  






	3.  	  	Nothing
in this Agreement shall be deemed to grant from BDY to Employee a           license,
expressly or by implication, under any patent or patent application,           copyright,
trademark, trade secret or other proprietary right owned or           controlled by BDY.  






	4.  	  	All
Confidential Information (including all copies thereof) shall at all times
          remain the sole property of BDY. Employee shall have no intellectual property
          rights in the Confidential Information and, in furtherance thereof, Employee
          hereby assigns to BDY all rights to any intellectual property that he invents
as           a result, directly or indirectly, of his employment by BDY or the disclosure
to           him of Confidential Information. This Agreement shall remain in effect for
seven           (7) years following the date all Confidential Information is removed (by
          destruction or return to BDY) from the possession of Employee.  






	5.  	  	Employee
shall not remove any proprietary, copyright, trade secret or other           legend from
any form of any Confidential Information, and shall promptly comply           with any
written request from BDY to add to or modify any such legend as BDY may           deem
necessary to protect its intellectual property rights.  









 
	 	 
	 











	6.  	  	Employee
agrees that a breach or threatened breach by him of this Agreement will           result
in irreparable and material damages to BDY that cannot be adequately           addressed
by monetary or other damages. Accordingly, Employee agrees that in           addition to
other remedies available at law or otherwise, BDY may obtain an           injunction or
other equitable remedy, without bond or requirement for proof of           actual or
likely damages, in any court of competent jurisdiction, in the event           of such
breach or threatened breach by Employee to strictly enforce this           Agreement.  






	7.  	  	This
Agreement may not be amended or altered, nor any breach or obligation           waived,
unless such amendment, alteration or waiver is in a writing signed by           BDY that
conspicuously notes that it is permitting Employee to amend or alter           this
Agreement, or BDY is waiving an obligation or breach by Employee hereunder.           No
course of dealings shall affect the interpretation or enforcement of this
          Agreement, nor shall any waiver by BDY of any obligation or breach by Employee
          be implied to be a waiver by BDY of any other obligation or breach by Employee
          not expressly granted.  






	8.  	  	This
Agreement is binding upon Employee and his successors and permitted           assigns. If
any provision of this Agreement is held by any competent authority           to be
invalid or unenforceable in whole or in part, the validity of the other
          provisions of this Agreement and the remainder of the provision in question
          shall not be affected thereby.  






	9.  	  	This
Agreement shall be governed by the laws of the State of New Jersey, without
          giving effect to the conflicts of law provisions thereof. Any dispute or
          controversy arising out of this Agreement shall be commenced and maintained in
a           federal or state court of appropriate jurisdiction in the State of New Jersey
          and Employee does hereby, for that sole purpose, consent to the jurisdiction of
          such federal or state court in the State of New Jersey. Employee hereby waives
          all rights to settle any dispute or controversy hereunder by arbitration and
          acknowledges that the rules of evidence then in effect and applicable to the
          court in which any such dispute or controversy is maintained shall be the only
          rules of evidence applicable to such dispute or controversy. Employee agrees
          that this Agreement embodies his complete understanding with respect to the
          disclosure and use of Confidential Information between him and BDY and
          supersedes all prior oral and written agreements, commitments and
understandings           with respect to the subject matter hereof.  








 
	 	 
	 
















        IN
WITNESS WHEREOF, this Agreement has been executed as of the day and year first above
written. 



	 	 	  	       EMPLOYEE

       /s/ Bradley Glassman
       Name: Bradley Glassman